Detect, Monitor, Mitigate Neurodegenerative Diseases 10X Faster

Revelis is on a mission to improve access and accuracy of life-changing tests to detect multiple neurological diseases of patients, upto 5 years earlier than before.

right

Revelis envisions a world where every neurological disease has a treatment through a technology first development process.

Revelis has pioneered a new approach to target discovery and development of technology first solutions on high-quality, high-density data with scalable computational capabilities.

Revelis was created with the strong belief that the technology development process for diagnosing neurodegenerative diseases can and should be better.

right

A revolutionary, integrated technology platform for connecting, measuring and monitoring neuro diseases

To usher in the next generation and deliver what patients need now, Revelis is replacing the linear drug development process with a holistic tech platform.

right

Recent Updates

Grant from Alzheimer’s Drug Discovery Fund - Gates Foundation
July 13, 2021
Grant from Alzheimer’s Drug Discovery Fund - Gates Foundation
July 13, 2021
Grant from Alzheimer’s Drug Discovery Fund - Gates Foundation
July 13, 2021
Grant from Alzheimer’s Drug Discovery Fund - Gates Foundation
July 13, 2021
right